Embecta discontinues insulin patch pump program, plans restructuring
Embecta (Nasdaq:EMBC) today announced that it’s bowing out of a significant diabetes technology market amid a new restructuring effort. Our sister site, Drug Delivery Business News, reports that the BD Diabetes spinoff is discontinuing its insulin patch …